Helissey P, Giorgi-Renault S, Renault J, Cros S
Chem Pharm Bull (Tokyo). 1989 Sep;37(9):2413-6. doi: 10.1248/cpb.37.2413.
With the aim of obtaining new antitumor drugs more active than previously described 11H-indolo[3,2-c]quinoline-1,4-diones and 7,8,9,10-tetrahydro-11H-indolo[3,2-c]quinoline-1,4-diones, the synthesis and activities of a series of 3-substituted 11H-pyrido[3',4':4,5]pyrrolo[3,2-c]quinoline-1,4-diones and of 7,8,9,10-tetrahydro-11H-pyrido-[3',4':4,5]pyrrolo[3,2-c] quinoline-1,4-diones were studied. Some quinones were more cytotoxic in vitro towards L1210 leukemia cells but were not active in vivo towards murine P388 leukemia.
为了获得比先前描述的11H-吲哚并[3,2-c]喹啉-1,4-二酮和7,8,9,10-四氢-11H-吲哚并[3,2-c]喹啉-1,4-二酮活性更高的新型抗肿瘤药物,对一系列3-取代的11H-吡啶并[3',4':4,5]吡咯并[3,2-c]喹啉-1,4-二酮和7,8,9,10-四氢-11H-吡啶并[3',4':4,5]吡咯并[3,2-c]喹啉-1,4-二酮的合成及活性进行了研究。一些醌类化合物在体外对L1210白血病细胞具有更高的细胞毒性,但对小鼠P388白血病在体内无活性。